UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Cuts Stock Holdings in Danaher Corporation $DHR

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its stake in Danaher Corporation (NYSE:DHR) by 4.1% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,012,228 shares of the conglomerate’s stock after selling 213,633 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Danaher were worth $954,729,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the company. EP Wealth Advisors LLC purchased a new stake in Danaher in the 2nd quarter valued at about $3,807,000. Northwestern Mutual Wealth Management Co. grew its stake in Danaher by 303.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock valued at $56,777,000 after buying an additional 186,584 shares in the last quarter. Puzo Michael J purchased a new stake in shares of Danaher in the second quarter worth about $8,624,000. Madison Asset Management LLC purchased a new position in Danaher during the second quarter valued at approximately $85,451,000. Finally, Legal & General Group Plc increased its holdings in Danaher by 1.0% during the 4th quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock worth $1,029,061,000 after acquiring an additional 43,169 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Trading Up 0.3%

NYSE DHR opened at $216.41 on Friday. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The stock has a market cap of $152.13 billion, a P/E ratio of 38.44, a price-to-earnings-growth ratio of 2.69 and a beta of 0.78. The stock has a 50 day simple moving average of $199.46 and a two-hundred day simple moving average of $192.52. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company’s revenue was up 5.5% on a year-over-year basis. During the same period last year, the company earned $0.77 earnings per share. On average, analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current year.

Analyst Ratings Changes

DHR has been the subject of several research analyst reports. HSBC dropped their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Stifel Nicolaus decreased their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. TD Cowen dropped their price objective on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Wells Fargo & Company cut their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 22nd. Finally, Citigroup initiated coverage on Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target on the stock. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $228.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.